Where Are the Questions About Firearms?

Karen Donelan(Massachusetts General Hospital), Peter T. Masiakos(Massachusetts General Hospital), Chana A. Sacks(Harvard University), Giancarlo Buonomo(Massachusetts General Hospital), Sophia Guzikowski, Alexandra Galls(MGH Institute of Health Professions)
Annals of Surgery
August 25, 2022
10.1097/sla.0000000000005686
Cited by 1

Related Papers

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
|PubMed|1999|122
Paradigm Shifts in Heart-Failure Therapy — A Timeline
|New England Journal of Medicine|2014|114
Müllerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
|Journal of Biological Chemistry|2000|86
Oral Anticoagulant Utilization in the United States and United Kingdom
|Journal of General Internal Medicine|2020|79